Alterity Therapeutics (ATHE) Acquisitions (2009 - 2015)

Alterity Therapeutics' Acquisitions history runs 5 years deep, the most recent figure standing at $20.9 million for Q4 2015.

• On a quarterly basis, Acquisitions fell 29.97% year-over-year to $20.9 million in Q4 2015; TTM through Dec 2015 was $31860.7 billion, a 0.0% change from a year earlier, with the FY2014 full-year figure at $31372.1 billion, changed N/A from the prior year.
• Acquisitions declined to $20.9 million in Q4 2015 per ATHE's latest filing, from $29.9 million in the prior quarter.
• Across five years, Acquisitions topped out at $31860.7 billion in Q2 2014 and bottomed at $9.4 million in Q2 2011.
• The 3-year median for Acquisitions is $25.4 million (2014), against an average of $7965.2 billion.
• Across the five-year window, Acquisitions soared 79.51% in 2011 and decreased 29.97% in 2015, its largest moves.
• Year by year, Acquisitions stood at $9.4 million in 2011, then surged by 218.24% to $29.9 million in 2014, then dropped by 29.97% to $20.9 million in 2015.
• Per Business Quant, the three latest ATHE Acquisitions figures stand at $20.9 million (Q4 2015), $29.9 million (Q4 2014), and $31860.7 billion (Q2 2014).